Key Insights

Highlights

Success Rate

87% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

6.7%

3 terminated out of 45 trials

Success Rate

87.0%

+0.4% vs benchmark

Late-Stage Pipeline

7%

3 trials in Phase 3/4

Results Transparency

10%

2 of 20 completed with results

Key Signals

2 with results87% success

Data Visualizations

Phase Distribution

31Total
Not Applicable (19)
Early P 1 (1)
P 1 (6)
P 2 (2)
P 3 (2)
P 4 (1)

Trial Status

Completed20
Unknown13
Recruiting3
Terminated3
Withdrawn2
Active Not Recruiting2

Trial Success Rate

87.0%

Benchmark: 86.6%

Based on 20 completed trials

Clinical Trials (45)

Showing 20 of 20 trials
NCT07681531Not ApplicableNot Yet RecruitingPrimary

Laser Ablation Versus Conventional Fistulectomy for Uncomplicated Perianal Fistula

NCT07676825Not ApplicableActive Not RecruitingPrimary

This Study Compares the Conventional Cutting Seton Technique and a GLUBRAN®-Coated Seton in High Perianal Fistula Treatment. The Study Aims to Determine Whether the GLUBRAN®-Coated Seton Improves Healing, Reduces Postoperative Pain and Recurrence, and Better Preserves Anal Continence.

NCT07579715Not ApplicableCompleted

Comparison Of Surgical Outcomes Between Ligation Of Intersphincteric Fistula Tract And Fistulotomy With Seton In Perianal Fistula

NCT04519671Phase 1Terminated

Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease

NCT07519850Recruiting

The Impact of Perianal Disease on Patient's Sex Life

NCT07477496Recruiting

Recurrence and Anal Fistula Patient Reported Outcomes Trial

NCT04549311Phase 3Completed

Perianal Abscess Recurrence and Fistula Formation: Antibiotics Following Incision and Drainage Trial

NCT03707769Not ApplicableCompletedPrimary

TIPS Microspheres for Perianal Fistula

NCT07236047Not ApplicableNot Yet RecruitingPrimary

Comparing Three Surgical Techniques for the Treatment of Transsphincteric Perianal Fistula: (1) Traditional Fistulotomy (Lay Open), (2) Ligation of the Intersphincteric Tract (LIFT) With Adjunctive Endo Fistula Laser Ablation, and (3) Open LIFT Procedure Followed by LASER

NCT06527833Not ApplicableCompletedPrimary

Procedure-Specific Approach To Minimize Fistulaization of The Perianal Abscess Cavity After Surgical Drainage

NCT05626023Phase 1CompletedPrimary

A Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease

NCT05836883Phase 1TerminatedPrimary

Study of ExoFlo for the Treatment of Perianal Fistulas

NCT06616662CompletedPrimary

Transsphincteric Fistula Management Using LIFT and MAF

NCT04847739Phase 2Active Not RecruitingPrimary

Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)

NCT06446635Not ApplicableRecruitingPrimary

Semiflex Assisted Vacuum Therapy for Perianal Abscesses/Sinuses and Fistula: a Pilot Study

NCT06441526Phase 3CompletedPrimary

Surgical Closure vs Anti-TNF in the Treatment of Perianal Fistulas in Crohn's Disease (PISA-II): a Comprehensive Cohort Design

NCT04722965Not ApplicableWithdrawnPrimary

Treatment of Lower Transsphincteric Perianal Fistula: Fistulotomy With Marsupialization vs Open Wound

NCT06314945CompletedPrimary

Diagnostic Value of Recto-perineal Ultrasound in Perianal Fistula

NCT05385887Not ApplicableUnknownPrimary

Antibiotic Treatment foLlowing Surgical drAinage of Perianal abScess; the ATLAS Trial

NCT05990569Not ApplicableUnknown

Pudendal Nerve Block With Bupivacaine Alone and Bupivacaine With Methylene Blue for Postoperative Analgesia

Scroll to load more

Research Network

Activity Timeline